Joan Mannick
Guest on a previous podcast episode discussing short-term human studies on Rapamycin.
Common Themes
Videos Mentioning Joan Mannick
175 - The biology of aging, rapamycin, and other interventions that target the aging process
Peter Attia MD
A researcher who conducted clinical trials with everolimus (a rapamycin derivative) at Novartis, showing its ability to boost vaccine response in older adults, and later involved with RestoreBio.
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
Peter Attia MD
Co-founder and Chief Medical Officer of Restore Biotherapeutics, trained in infectious disease, and an expert in Rapamycin analogs.
Dr. Peter Attia — Longevity Drugs, Alzheimer's Disease, and More
Tim Ferriss
Lead author on a 2014 study for Everolimus (a Rapamycin derivative) showing an improved immune response in 65-year-olds, counteracting expected immune-suppressing effects.
300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more
Peter Attia MD
Guest on a previous podcast episode discussing short-term human studies on Rapamycin.
Supplements for Longevity & Their Efficacy | Dr. Peter Attia
Andrew Huberman
Researcher who published a paper in 2014 demonstrating that everolimus enhanced immunity.
"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)
Peter Attia MD
Mentioned as a past podcast guest discussing aging.